US4962094A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Glucan dietary additives
Assignee: Alpha Beta Technology Inc
•
Filing: 1988-10-28
•
Granted: 1990-10-09
•
Expires: 2008-10-28
Abstract
Abstract Compositions useful in the treatment of dietary disorders, and as dietary additives to provide a source of fiber, of short chain fatty acids and as bulking agents in humans and animals, as well as methods of use therefor. The compositions are based on whole beta -glucans.
Inventors
- 👤 Spiros Jamas
- 👤 D. Davidson Easson, Jr.
- 👤 Bruce R. Bistrian
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 00:08
CPC Classifications
A; A23; A23L; A23L33/00; A23L33/20; A23L33/21; A23L33/24; A23L29/00; A23L29/20; A23L29/269; A23L29/271; A61; A61P; A61P1/00; A61P1/10; A61P3/00; A61P3/06
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
40 words
A method of providing a source of fiber in the diet of a mammal comprising administering to the mammal an amount of whole yeast β-glucan sufficient to aid digestion, reduce dehydration or reduce the serum cholesterol level in the mammal.
Claim 2
Independent Claim
40 words
A method of providing a source of fiber in the diet of a mammal comprising administering to the mammal an amount of whole yeast β-glucan sufficient to aid digestion, reduce dehydration or reduce the serum cholesterol level in the mammal.
Claim 3
Dependent Claim
16 words
A method of claim 1 wherein the whole yeast β-glucan is in a biologically acceptable carrier.
Claim 4
Dependent Claim
24 words
A method of claim 2 wherein the carrier is sterile saline or water, and the composition is administered orally or through a feeding tube.
Claim 5
Dependent Claim
23 words
A method of claim 2 wherein the whole yeast β-glucan is administered to the mammal as part of a complete nutritional food formulaton.
Claim 6
Dependent Claim
27 words
A method of claim 1 wherein the bulking and digestibility of the fiber is altered by increasing or decreasing the relative proportion of β(1-3) and β(1-6) linkages.
Claim 7
Independent Claim
38 words
A method of providing a fecal bulking agent to a mammal comprising administering to the mammal an amount of whole yeast β-glucan sufficient to absorb excess water thereby reducing dehydration, bowel irritation and chronic diarrhea in the mammal.
Claim 8
Independent Claim
38 words
A method of providing a fecal bulking agent to a mammal comprising administering to the mammal an amount of whole yeast β-glucan sufficient to absorb excess water thereby reducing dehydration, bowel irritation and chronic diarrhea in the mammal.
Claim 9
Dependent Claim
16 words
A method of claim 6 wherein the whole yeast β-glucan is in a biologically acceptable carrier.
Claim 10
Dependent Claim
25 words
A method of claim 7 wherein the carrier is sterile saline solution or water, and the composition is administered orally or through a feeding tube.
Claim 11
Dependent Claim
22 words
A method of claim 7 wherein the whole yeast β-glucan is administered to the mammal as part of a complete nutritional feed.
Claim 12
Independent Claim
33 words
A method of providing a source of short chain fatty acids to a mammal comprising administering to the mammal an amount of whole yeast β-glucan sufficient to aid digestion in improved intestinal function.
Claim 13
Independent Claim
33 words
A method of providing a source of short chain fatty acids to a mammal comprising administering to the mammal an amount of whole yeast β-glucan sufficient to aid digestion in improved intestinal function.
Claim 14
Independent Claim
32 words
A method of treating gastroenteral disorders and improving digestion in mammals comprising administering to the mammal a quantity of whole yeast β-glucan sufficient to provide a source of short chain fatty acids.
Claim 15
Independent Claim
32 words
A method of treating gastroenteral disorders and improving digestion in mammals comprising administering to the mammal a quantity of whole yeast β-glucan sufficient to provide a source of short chain fatty acids.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-10-08 | 1994-04-09 | 1994-10-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-10-08 | 1998-04-09 | 1998-10-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-10-08 | 2002-04-09 | 2002-10-09 | $7700.00 | Window Closed / Lapsed |